|Conflict of Interest|
Mailis Gagnon is member of the Advisory Board for Lyrica (Pfizer Canada) and Cymbalta (Eli LillyCanada) and has received a research grant from Pfizer Canada (2009), an unrestricted educational grant from Purdue Pharma, Valeant Canada Ltd and Paladin Labs (2010) and honoraria for talks (Pfizer Canada, Eli Lilly Canada). She is also advisor to Elafi Digital Media Inc., a company owned by her husband.
Central Pain Syndrome|
Medications Neurological Disorders Chronic Pain Management
Neuroscience Fibromyalgia Shingles Peripheral Neuropathy
Site Design & Content © 2010 Angela Mailis-Gagnon MD All registered trademarks belong to their respective owners.
|User Terms | Conflict of Interest | Privacy Statement|